RW

Robert Wenham

Advisor at Sonnet BioTherapeutics

Dr. Robert Wenham is both Chair of the Department of Gynecologic Oncology and a Senior Member of the Program of Chemical Biology and Molecular Medicine at Moffitt Cancer Center, as well as Professor in the Department of Interdisciplinary Oncology at the Morsani School of Medicine. Dr. Wenham has a strong interest in research and is a principal investigator for sponsored and investigator-initiated clinical trials to improve cancer care for women, focusing primarily on the use of novel drugs and cellular and other immunotherapies for the treatment of gynecologic cancers. He has received the Molly Cade Ovarian Cancer Research Award from the Gynecologic Cancer Foundation. He also serves as a chair or member of several clinical trial steering committees, data safety monitoring committees, and advisory boards. Dr. Wenham enjoys the challenge of helping women with complex issues and the opportunity to offer them cutting-edge therapies, from the latest chemotherapy approaches to biological targeted therapies, minimally invasive surgery and clinical trials. He is also an expert in pelvic exenterative surgery, a very complex operation that offers hope of possible cure for certain patients with gynecologic cancer. Dr. Wenham points out that life expectancy for certain women’s cancers, such as ovarian cancer, have dramatically improved over the last 30 years due to advancements in therapy.

Timeline

  • Advisor

    Current role